[
    {
        "title": "**A) Serum sample collection**",
        "body": []
    },
    {
        "title": "**1.**",
        "body": "Filled red-top blood-collection tubes should be kept upright for 30-60 min after the blood was drawn at room temperature to allow the clot to form."
    },
    {
        "title": "**\\!CAUTION**",
        "body": "All experiments involving humanss would be performed according to institutional and governmental guidelines."
    },
    {
        "title": "**▲CRITICAL STEP**",
        "body": "Use red-top \\(serum) silicon-coated tubes with no additives, rather than serum separator tubes. These tubes, without additives, allow the red blood cells to form a clot, which also includes white blood cells and platelets, and which can be separated from the serum by centrifuging. The red-top tubes do not have to be full to be used."
    },
    {
        "title": "**2.**",
        "body": "Centrifuge the blood sample after clotting for 30–60 min using a horizontal rotor \\(swing-out head) for 20 min at 1100–1300 × g at room temperature. If the blood is not to be centrifuged immediately after clotting, the tubes should be refrigerated at 4 ºC for no longer than 4 h."
    },
    {
        "title": "**\\!CAUTION**",
        "body": [
            "Excessive centrifuge speed \\(over 2000 ×",
            {
                "title": "g)",
                "body": "may cause tube breakage, exposure to blood serum, and possible injury."
            }
        ]
    },
    {
        "title": "**3.**",
        "body": "Use a pipette to transfer the serum. If more than one tube is drawn per sample, pull the serum from both tubes into a 15 mL conical tube and mix. Pipette the serum into labeled cryovials and close the caps tightly. Place all aliquots upright in a specimen box or rack at 4 °C"
    },
    {
        "title": "**▲CRITICAL STEP**",
        "body": "Do not pour the serum. This process should be completed within 1 h of centrifugation. Take care not to pick up red blood cells when aliquoting by keeping the pipette above the red blood cell layer and leaving a small amount of serum in the tube. Check that all aliquot vial caps are secure and that all vials are labeled."
    },
    {
        "title": "**■PAUSE POINT**",
        "body": "The serum samples can be stored at 4 °C for up to 1 month."
    },
    {
        "title": "**B) Preparation of peptide 1 and probe 1**",
        "body": []
    },
    {
        "title": "**Resin preparation**",
        "body": []
    },
    {
        "title": "**4.**",
        "body": "The Rink amide resin \\(312 mg, 0.8 mmol/g, 0.25 mmol, 1.0 equiv.) was weighed out into a plastic peptide-synthesis vessel and allowed to swell in DCM \\(10.0 mL) for 1.0 h."
    },
    {
        "title": "**Coupling cycle**",
        "body": []
    },
    {
        "title": "**5.**",
        "body": "The Rink amide resin was washed by an intensive cycle of DMF\\( 5×10 mL, 2 min each) and the following  amino acids \\[Fmoc-Arg\\(Pbf)-OH; Fmoc-Lys\\(Boc)-OH; Fmoc-Lys\\(Alloc)-OH; Fmoc-Gln\\(Trt)-OH; Fmoc-Glu\\(OtBu)-OH; Fmoc-Phe-OH; Fmoc-Met-OH; Fmoc-Leu-OH; Fmoc-Gly-OH; Fmoc-Pro-OH] were attached under microwave radiation conditions \\(35 W, 60 ± 5 °C, 20 min) according to a standard protocol: Fmoc-AA-OH \\(0.75 mmol, 3.0 equiv.), PyBOP \\(0.75 mmol, 3.0 equiv.), and DIPEA \\(1.5 mmol, 6 equiv.) in DMF \\(10.0 mL)."
    },
    {
        "title": "**Deprotection**",
        "body": []
    },
    {
        "title": "**6.**",
        "body": "The Fmoc protection group was removed by agitation with 8.0 mL of 20 % piperidine/DMF \\(vol/vol) under microwave radiation conditions \\(35 W, 60 ± 5 °C, 30 s), and the solvent was then removed by vacuum filtration. Second, the Fmoc protection group was removed by agitation with 8.0 mL of 20 % piperidine/DMF \\(vol/vol) under microwave radiation conditions \\(35 W, 60 ± 5 °C, 5.0 min), and the solvent was then removed by vacuum filtration."
    },
    {
        "title": "**7.**",
        "body": "After Fmoc-Lys\\(Alloc)-OH was coupled, the Alloc group was removed by adding Pd\\(PPh<sub>3</sub>)<sub>4</sub> \\(0.05 mmol, 0.2 equiv.) and PhSiH<sub>3</sub> \\(12 mmol, 48 equiv.) in DCM \\(10 mL) under argon for 30 min. Terpyridine \\(1.5 mmol, 6.0 equiv.), 2-\\(4-\\(\\(2-carboxyethyl)\\(ethyl)amino)styryl)-1,1,3-trimethyl-1H-benzo\\[e]indol-3-ium \\(0.75 mmol, 3.0 equiv.), and 2-\\(4,7,10-tris\\(2-\\(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclodecan-1-yl) acetic acid \\(0.75 mmol, 3.0 equiv.) were then coupled at room temperature."
    },
    {
        "title": "**Cleavage**",
        "body": []
    },
    {
        "title": "**8.**",
        "body": "The product was cleaved from Rink amide resin using a cleavage cocktail of TFA-Tis-H<sub>2</sub>O \\(95:2.5:2.5, 10 mL) for 3 h."
    },
    {
        "title": "**9.**",
        "body": [
            "TFA was removed and the peptide was precipitated three times by cold diethyl ether and centrifuged at speed \\(1000 ×",
            {
                "title": "g)",
                "body": "for 8 min at room temperature."
            }
        ]
    },
    {
        "title": "**Purification and preparation of peptide 1**",
        "body": []
    },
    {
        "title": "**10.**",
        "body": "The crude peptides were purified by high-performance liquid chromatography on an RP18-column using water/CH<sub>3</sub>CN \\(with 0.05 % TFA) as the elution buffer."
    },
    {
        "title": "**11.**",
        "body": "The solid was dissolved in water \\(20 mL) acidified with hydrochloric acid \\(0.1 N, 5 mL) and lyophilized. This step was repeated three times. The product was identified by MALDI-TOF."
    },
    {
        "title": "**12.**",
        "body": "Complexation of the ligand with Gd \\(III)-ion was performed by the dropwise addition of an aqueous solution of GdCl<sub>3</sub> to an aqueous solution of the ligand at pH 3.0. The mixture was then stirred for 6 h, and the pH was adjusted to 6.5 using a 1M solution of NaOH. The final Gd \\(III)-peptide"
    },
    {
        "title": "**1**",
        "body": "complex was obtained as a purple powder after lyophilization \\(excess GdCl<sub>3</sub> was dialysed in MilliQ grade water). The formation of the complex was identified by MALDI-TOF."
    },
    {
        "title": "**13.**",
        "body": "Peptide"
    },
    {
        "title": "**1**",
        "body": "was dissolved in TBS buffer \\(pH 7.4, 50.0 mM Tris, 50.0 mM NaCl) at a concentration of 1 mM."
    },
    {
        "title": "**\\!CAUTION**",
        "body": "The powder of peptide"
    },
    {
        "title": "**1**",
        "body": "may be inhaled. Appropriate personal protective clothing should be worn during the experiment and the preparation and use should be carried out in a clean bench to avoid microbial contamination. All solutions must be filtered prior to use."
    },
    {
        "title": "**■PAUSE POINT**",
        "body": "The peptide"
    },
    {
        "title": "**1**",
        "body": "solution should be stored at 4 °C and can remain stable for at least 1 month."
    },
    {
        "title": "**Preparation of probe 1**",
        "body": []
    },
    {
        "title": "**14.**",
        "body": "Add the same eq. of FeCl<sub>2</sub> to the peptide"
    },
    {
        "title": "**1**",
        "body": "solution. The final probe"
    },
    {
        "title": "**1**",
        "body": "was obtained as a purple powder after lyophilization \\(excess FeCl<sub>2</sub> was dialysed in MilliQ grade water)."
    },
    {
        "title": "**\\!CAUTION**",
        "body": "The FeCl<sub>2</sub> solution must be filtered prior to use. It is strongly recommended to perform the experiment at 4 °C, because Fe<sup>2+</sup> is oxidized by air at higher temperatures."
    },
    {
        "title": "**15.**",
        "body": "Incubate the mixture at 4 °C for at least 24 h to allow formation of the Fe-peptide"
    },
    {
        "title": "**1**",
        "body": "complex and further aggregation into probe"
    },
    {
        "title": "**1**",
        "body": "."
    },
    {
        "title": "**■PAUSE POINT**",
        "body": "The peptide"
    },
    {
        "title": "**1**",
        "body": "solution should be stored at 4 °C and may remain stable for at least 1 month."
    },
    {
        "title": "**▲CRITICAL STEP**",
        "body": "Although the process of Fe-peptide"
    },
    {
        "title": "**1**",
        "body": "complex formation takes < 1.0 min, the aggregation process takes longer. The mixture should thus be incubated for at least 24 h to allow the Fe\\(II)-peptide"
    },
    {
        "title": "**1**",
        "body": "complex to aggregate into probe"
    },
    {
        "title": "**1**",
        "body": "."
    }
]